Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Fish and Richardson
Covington
UBS
Farmers Insurance
US Army
Argus Health
Harvard Business School
Deloitte

Generated: December 19, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR STENDRA

« Back to Dashboard

Clinical Trials for Stendra

Trial ID Title Status Sponsor Phase Summary
NCT00790751 Research Evaluating an Investigational Medication for Erectile Dysfunction - General ED Completed VIVUS, Inc. Phase 3 This study is being conducted to compare the safety and efficacy of 3 doses of avanafil to placebo in men with mild to severe erectile dysfunction.
NCT00809471 Research Evaluating an Investigational Medication for Erectile Dysfunction - Diabetic ED (REVIVE-D) Completed VIVUS, Inc. Phase 3 This study is being conducted to compare the safety and efficacy of 2 doses of avanafil to placebo in diabetic men with mild to severe erectile dysfunction.
NCT00853606 Long-Term Safety and Efficacy Study of Avanafil in Men With Erectile Dysfunction Completed VIVUS, Inc. Phase 3 This open-label study is being conducted to evaluate the long-term safety, tolerability, and efficacy of avanafil in men with mild to severe erectile dysfunction. Approximately 400 subjects will be enrolled and treated with avanafil for up to 52 weeks.
NCT00895011 Research Evaluating an Investigational Medication for Erectile Dysfunction - Post-Prostatectomy Completed VIVUS, Inc. Phase 3 The objectives of this study are to evaluate the safety and efficacy of two doses of avanafil in the treatment of adult males for erectile dysfunction following bilateral nerve-sparing radical prostatectomy.
NCT01768676 Study Evaluating the Effects of Avanafil on Semen Parameters Completed VIVUS, Inc. Phase 4 The purpose of this study is to determine whether avanafil will affect different aspects of sperm production.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Stendra

Condition Name

Condition Name for Stendra
Intervention Trials
Erectile Dysfunction 5
Vision 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Stendra
Intervention Trials
Erectile Dysfunction 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Stendra

Trials by Country

Trials by Country for Stendra
Location Trials
United States 81
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Stendra
Location Trials
New York 5
Louisiana 5
Florida 5
California 5
Arizona 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Stendra

Clinical Trial Phase

Clinical Trial Phase for Stendra
Clinical Trial Phase Trials
Phase 4 2
Phase 3 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Stendra
Clinical Trial Phase Trials
Completed 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Stendra

Sponsor Name

Sponsor Name for Stendra
Sponsor Trials
VIVUS, Inc. 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Stendra
Sponsor Trials
Industry 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Federal Trade Commission
Queensland Health
Medtronic
McKinsey
Cipla
Citi
Harvard Business School
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.